Most of the sporadic reports dealing with this problem have been in association with the treatment of invasive carcinoma of the cervix, but another condition in which it may be encountered is in the treatment of pelvic malignant disease in young women.
Here is the case of a girl who, in December 1958 at the age of 14, was found to be suffering from Hodgkin's disease. Over the next five years she received at intervals deep X-ray therapy for enlarged lymph glands in the neck, mediastinum and left axilla.
In March 1963, at the age of 19, she came with enlarged lymph nodes in both groins. In an attempt to preserve ovarian function during the required course of pelvic irradiation, two lead shields were fashioned and placed around both ovaries. Five days after laparotomy a two-week course of deep X-ray therapy was given. The patient displayed minimal side-effects and the shields were removed at a second laparotomy three weeks after the first. Menstruation recommenced three weeks later and has been regular ever since. The patient remains well. Acknowledgments: I should like to thank Mr G Pinker and Dr M Hulbert for permission to present this case.
Male Pseudohermaphroditism Audrey P Ward MB MRCOG (Samaritan Hospital, London)
The case presented is that of a chromosomal and gonadal male aged 18, reared as a female, with a perineal hypospadias, inguinal testes, powerfully developed muscles and no breast development.
"Present address: Paddington General Hospital, London
The patient first appeared at a gynecological clinic, complaining of primary amenorrhaea. The 17-ketosteroids were 113 mg/24 hours and 17-ketogenic steroids 19-2 mg/24 hours. No drumsticks were seen in a count of 500 neutrophils. There were forty-six chromosomes and the sex chromosomes XY. The plasma testosterone level was 0 393 ,ug/100 ml at the lower limit of the normal male range (0-32-1 -07 ,ug/100 ml).
At operation, typical testes, each with an epididymis and spermatic cord were found, and a hernial sac was present on each side. Microscopically, the tubules showed no signs of spermatogenesis and contained only Sertoli cells. There were abundant clusters of interstitial cells. Both testes and hernial sacs were removed. Post-operatively, an cestrogen supplement was given, and the plasma testosterone fell to 0-146 ,ug/24 hours.
Both patient and parents were told that, due to an error in development, 'she' had been born without a uterus or vagina, and that two hernive had been removed.
Death Following Tubal Insufflation with Carbon Dioxide N H N Gardner MB FRCS (St Thomas's Hospital, London) The patient, aged 35 years, was admitted for investigation of eighteen months primary infertility. General examination showed her to be otherwise healthy.
Insufflation was done, using a Provis insufflator, under a general anxsthetic. This machine uses carbon dioxide which is controlled by a manually operated valve and has a flowmeter. There is no control of the total volume of carbon dioxide which can be insufflated in a given time. The cervical canal was dilated to 6 mm diameter to take the Bonney's hollow metal dilator which was used as the insufflating cannula. Cardiac arrest took place during the third insufflation, the previous two having given opposing results.
External cardiac massage failed to maintain an adequate circulation and the left chest was therefore opened. Bubbles of gas could be seen in the superficial coronary vessels and a frothy mixture of blood and gas was aspirated from the right heart. The patient failed to regain consciousness and died three days later. At post-mortem examination there was a small tear at the internal os. The Fallopian tubes were patent.
No cases of death following insufflation with carbon dioxide could be found in the literature. Four cases of death using oxygen are recorded (Frommolt 1925 , Moench 1927 , Weitzman & Cohen 1937 and three using air (Mansfeld & Dudits 1934, Buxton & Southam 1958 , Puchowski 1960 ). In only one case were the tubes reported as patent.
Testicular Feminization Syndrome A S Townsend MRCOG (for George Pinker FRCOG) (St Mary's Hospital, London)
A woman of 19 came with a history of primary amenorrhcea. Examination revealed a tall young woman of normal female appearance: the breasts were well developed; minimal pubic and no axillary hair was present; the clitoris was hypertrophied and the vagina ended blindly, measuring 1'5 in. in length. On rectal examination, no uterus could be defined.
Chromosome studies showed the patient to be chromatin negative and to have a sex chromosome complement of XY. In view of these findings a diagnosis of the testicular feminization syndrome was made.
The gonads in these patients are believed to secrete androgens and cestrogens and the androgen level is reflected in a raised 17-ketosteroid fraction. In approximately 8-5 % of cases reviewed by Morris (1953) malignant change occurred in the gonads.
The urinary 17-ketosteroid and 17-ketogenic steroid output was found to be raised. Further investigation excluded an adrenal tumour and hyperplasia as being responsible for the high output. The plasma testosterone level was 1 96 pg/100 ml compared with the normal male range of 0-32-1-07 ,ug/100 ml. A review of the literature has failed to reveal a level as high as this.
In view of the high testosterone level, the question arises: have the gonads in this patient undergone malignant change? Further studies are being undertaken and in due course laparotomy will probably be undertaken.
Postscript: The testosterone analyses after administration of dexamethasone and gonadotrophin (HCG) were 1 8 ,g/100 ml and 2-4 ,ug/100 ml, respectively. There is no significant suppression after dexamethasone and a modest increase after HCG which is compatible with a testicular source. Laparotomy is being arranged. A patient aged 27 had a five-year history of systemic lupus erythematosus with progressive renal involvement. She had been treated continuously with steroids and, so that the dosage might be reduced, was given azathioprine, an immuno-suppressive and cytotoxic drug. Whilst on this regime she became pregnant but it was not recognized until the twelfth week because of previous menstrual irregularity. At this time it was found that the azathioprine had suppressed her marrow, her haemoglobin falling to 2-8 g (20%). The azathioprine was stopped, she was transfused and the marrow picture returned to normal. Despite blood urea levels of up to 250 mg/100 ml, severe proteinuria and a blood pressure of 170/110 mmHg the pregnancy continued. A superimposed pre-eclamptic toxemia developed at the 32nd week and an elective CQsarean section was performed at the 35th week. The baby weighed 1,729 g, hemopoiesis was unaffected and no abnormalities were detected clinically.
The increased incidence of abortion in pregnancies complicated by systemic lupus erythematosus may be due to some abnormal immune response to the pregnancy. This patient had two previous abortions and it may be that this pregnancy continued because of the azathioprine rather than in spite of it.
